Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study page adds new metadata and help sections and updates the author label to Prof. Silvia Novello. It standardizes the Intervention/Treatment heading and increases the page revision to v3.6.0.
    Difference
    1%
    Check dated 2026-06-12T16:43:39.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated from v3.5.4 to v3.5.5 on the page. It does not reflect changes to study content or eligibility.
    Difference
    0.1%
    Check dated 2026-06-05T12:53:53.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision has been updated from v3.5.3 to v3.5.4. This indicates a minor maintenance update to the page without altering study content.
    Difference
    0.1%
    Check dated 2026-05-15T02:13:44.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.5.3' has been added to the page, indicating the current build version of the interface (replacing the previous v3.5.2).
    Difference
    0.1%
    Check dated 2026-04-30T17:13:04.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.2, replacing the previous v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:55:42.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Updated location label from Napoli, Italy, 80131 to Naples, Italy, 80131 in the study locations.
    Difference
    0.1%
    Check dated 2026-03-25T21:18:01.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.